IFNA1 and COVID-19: IFN‐mediated immunity provides initial rapid protection against viral infection (McNab et al., 2015), and about 3.5% of patients with life‐threatening COVID‐19 show genetic aberrations in the type I IFN pathway (Zhang, Bastard, et al., 2020).